TP53 and cancer: Loss or mutation of p53 in tumor might have an impact on the recruitment and activity of myeloid and T cells, which contribute to immune evasion and tumor development, in addition, p53 can also affect the immune cells, causing different outcomes that can impede or promoting cancer progression (42, 43).